Mirae Asset Global Etfs Holdings Ltd. Prothena Corp Public LTD CO Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 21,218 shares of PRTA stock, worth $210,482. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,218
Previous 27,334
22.38%
Holding current value
$210,482
Previous $338,000
62.13%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding PRTA
# of Institutions
219Shares Held
34.2MCall Options Held
879KPut Options Held
791K-
Black Rock Inc. New York, NY3.86MShares$38.3 Million0.0% of portfolio
-
Adar1 Capital Management, LLC Austin, TX3.38MShares$33.5 Million3.14% of portfolio
-
Armistice Capital, LLC New York, NY2.24MShares$22.2 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.18MShares$21.6 Million0.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA1.27MShares$12.6 Million1.75% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $465M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...